IRMD
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
IRADIMED CORPORATION (IRMD) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B+); its weakest is Value (C). The rating has held at C+ for 5 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-12 | C (2.3) | C (2.3) | B+ (3.5) | B (3.2) | C+ (2.6) | C+ (2.8) |
| 2026-11-05 | C- (2.1) | C (2.3) | B+ (3.5) | B- (2.9) | C+ (2.7) | C+ (2.7) |
| 2026-10-29 | C (2.3) | C- (2.0) | B+ (3.5) | C+ (2.6) | C+ (2.7) | C+ (2.6) |
| 2026-10-22 | C (2.2) | C- (2.0) | B+ (3.5) | C+ (2.6) | C+ (2.6) | C+ (2.6) |
| 2026-10-15 | C (2.2) | C- (2.0) | B+ (3.5) | C (2.4) | C+ (2.6) | C+ (2.6) |